# Intensified Treatment Regimens for TB Meningitis: PK, PD and Tolerability Study

> **NCT01158755** · PHASE2 · COMPLETED · sponsor: **Universitas Padjadjaran** · enrollment: 60 (actual)

## Conditions studied

- Meningitis, Tuberculous
- Pharmacokinetics
- Pharmacodynamics
- Tolerability

## Interventions

- **DRUG:** Moxifloxacin

## Key facts

- **NCT ID:** NCT01158755
- **Lead sponsor:** Universitas Padjadjaran
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-10
- **Primary completion:** 2011-12
- **Final completion:** 2012-06
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2012-06-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01158755

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01158755, "Intensified Treatment Regimens for TB Meningitis: PK, PD and Tolerability Study". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT01158755. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*